CNX Therapeutics

Arvelle Therapeutics

This biopharmaceutical company develops and commercialises antiepileptic medicines to treat patients suffering from central nervous system disorders.

CeNeRx

This biopharmaceutical company develops clinical-stage therapeutics for central nervous system disorders, such as depression and pain, for patients and healthcare providers.

Kelso Pharma

This company provides specialty medicines and value-added pharmaceutical products to European healthcare systems and patients.

Bial

This company develops and manufactures pharmaceutical medicines for patients with neurological, cardiovascular and respiratory conditions.

Spherics

This pharmaceutical company develops oral drug delivery technologies to create improved therapeutic products for patients with central nervous system disorders and other medical conditions.

Cerevance

This pharmaceutical company develops therapies for neurodegenerative diseases and central nervous system disorders for patients and healthcare providers.

Minoryx

This biotechnology company develops orphan drugs and therapies for patients suffering from rare, life-threatening genetic diseases of the central nervous system.

Minoryx Therapeutic

This biotech company develops therapies for orphan central nervous system diseases, such as X-linked adrenoleukodystrophy, for patients with high unmet medical needs.